JIANGSU HANSOH PHARM FDA Approval ANDA 213472

ANDA 213472

JIANGSU HANSOH PHARM

FDA Drug Application

Application #213472

Application Sponsors

ANDA 213472JIANGSU HANSOH PHARM

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS50MG/VIAL0DECITABINEDECITABINE

FDA Submissions

UNKNOWN; ORIG1AP2022-04-15STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

JIANGSU HANSOH PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213472
            [companyName] => JIANGSU HANSOH PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"DECITABINE","activeIngredients":"DECITABINE","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DECITABINE","submission":"DECITABINE","actionType":"50MG\/VIAL","submissionClassification":"INJECTABLE;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.